WallStreetZenWallStreetZen

NYSE: CBT
Cabot Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CBT

Based on 2 analysts offering 12 month price targets for Cabot Corp

Min Forecast
$82.00+17.73%
Avg Forecast
$85.00+22.04%
Max Forecast
$88.00+26.35%

Should I buy or sell CBT stock?

Based on 2 analysts offering ratings for Cabot Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CBT's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CBT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CBT stock forecasts and price targets.

CBT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-03
lockedlocked$00.00+00.00%2025-08-05

1 of 1

Forecast return on equity

Is CBT forecast to generate an efficient return?

Company
32.97%
Industry
14.26%
Market
-62.31%
CBT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CBT forecast to generate an efficient return on assets?

Company
13.24%
Industry
6.5%
CBT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CBT earnings per share forecast

What is CBT's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$8.00+3.6%
Avg 2 year Forecast
$8.65+12.05%
CBT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CBT revenue forecast

What is CBT's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$3.9B+1.81%
Avg 2 year Forecast
$4.0B+4.95%
CBT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CBT earnings growth forecast

How is CBT forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
7.08%
Industry
4.5%
Market
16.01%
CBT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CBT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CBT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CBT revenue growth forecast

How is CBT forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
2.63%
Industry
2.63%
Market
11.86%
CBT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CBT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CBT vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
CBT$69.65$85.00+22.04%Buy
SSL$5.48N/AN/A
PRM$22.92$25.00+9.08%Strong Buy
HWKN$161.75$200.00+23.65%Buy
SXT$95.78$110.00+14.85%Buy
View Top Specialty Chemical Stocks

Cabot Stock Forecast FAQ

Is Cabot Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: CBT) stock is to Buy CBT stock.

Out of 2 analysts, 0 (0%) are recommending CBT as a Strong Buy, 1 (50%) are recommending CBT as a Buy, 1 (50%) are recommending CBT as a Hold, 0 (0%) are recommending CBT as a Sell, and 0 (0%) are recommending CBT as a Strong Sell.

If you're new to stock investing, here's how to buy Cabot stock.

What is CBT's earnings growth forecast for 2026-2027?

(NYSE: CBT) Cabot's forecast annual earnings growth rate of 7.08% is forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 4.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.01%.

Cabot's earnings in 2025 is $425,000,000.On average, 2 Wall Street analysts forecast CBT's earnings for 2026 to be $425,506,624, with the lowest CBT earnings forecast at $425,378,935, and the highest CBT earnings forecast at $425,628,992.

In 2027, CBT is forecast to generate $460,211,348 in earnings, with the lowest earnings forecast at $454,890,985 and the highest earnings forecast at $465,531,710.

What is CBT's revenue growth forecast for 2026-2027?

(NYSE: CBT) Cabot's forecast annual revenue growth rate of 2.63% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.

Cabot's revenue in 2025 is $3,815,000,000.On average, 2 Wall Street analysts forecast CBT's revenue for 2026 to be $206,637,289,235, with the lowest CBT revenue forecast at $206,246,508,617, and the highest CBT revenue forecast at $207,028,069,854.

In 2027, CBT is forecast to generate $213,013,477,554 in revenue, with the lowest revenue forecast at $210,828,404,716 and the highest revenue forecast at $215,198,550,391.

What is CBT's forecast return on assets (ROA) for 2026-2028?

(NYSE: CBT) forecast ROA is 13.24%, which is higher than the forecast US Specialty Chemicals industry average of 6.5%.

What is CBT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CBT price target, the average CBT price target is $85.00, with the highest CBT stock price forecast at $88.00 and the lowest CBT stock price forecast at $82.00.

On average, Wall Street analysts predict that Cabot's share price could reach $85.00 by Oct 3, 2026. The average Cabot stock price prediction forecasts a potential upside of 22.04% from the current CBT share price of $69.65.

What is CBT's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: CBT) Cabot's current Earnings Per Share (EPS) is $7.72. On average, analysts forecast that CBT's EPS will be $8.00 for 2026, with the lowest EPS forecast at $8.00, and the highest EPS forecast at $8.00. In 2027, CBT's EPS is forecast to hit $8.65 (min: $8.55, max: $8.75).

What is CBT's forecast return on equity (ROE) for 2026-2028?

(NYSE: CBT) forecast ROE is 32.97%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.